CryoPort, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CryoPort, Inc. on May 8, 2009, reporting events that occurred on May 4, 2009. The filing addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Resignation: Gary Cannon resigned from the Board of Directors on May 4, 2009. He will continue to serve as an outside general legal counsel and join the advisory board.
- Appointment: Carlton M. Johnson was appointed to the Board of Directors on May 4, 2009, to fill the vacancy left by Mr. Cannon.
- Covenant Compliance: Mr. Johnson's appointment fulfills a debt covenant agreement with BridgePointe Master Fund Ltd., requiring a representative of BridgePointe on the board.
Outlook, Risks, and Management Commentary
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. The appointment of Mr. Johnson is noted as a compliance measure regarding existing debt covenants. Mr. Johnson brings experience as In-House Legal Counsel for Roswell Capital Partners LLC and has served on the boards of Peregrine Pharmaceuticals Inc. and Patriot Scientific, Inc.
Key Facts for Investor Verification
- Verify the specific terms of the debt covenant with BridgePointe Master Fund Ltd. that necessitated the board appointment.
- Confirm the continued role of Gary Cannon as outside general legal counsel and his compensation arrangements, if any.
- Review the Company's most recent 10-K or 10-Q for financial data, as this 8-K contains no financial metrics.